Compare Boeing Co (BA) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boeing Co vs Moderna, Inc. — how do they compare? Boeing Co trades at $233.4 (market cap $184.35B), while Moderna, Inc. trades at $60.75 (market cap $24.18B). The key difference: Boeing Co is far larger — about 7.6× Moderna, Inc.'s market cap, and Boeing Co pays a 0.03% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| BA | MRNA | |
|---|---|---|
Market Cap | $184.35B | $24.18B |
Volume | 7,591,579 | — |
Sector | Industrials | Health |
52-Week High | $252.15 | $81.80 |
52-Week Low | $179.12 | $22.36 |
Enterprise Value | $210.23B | $20.33B |
Dividend Yield | 0.03% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Boeing Co
The Boeing Company, together with its subsidiaries, develops, produces, and markets commercial jet aircraft, as well as provides related support services to the commercial airline industry worldwide. The Company also researches, develops, produces, modifies, and supports information, space, and defense systems, including military aircraft, helicopters and space and missile systems.
Read more on BA →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
